S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
Log in

Minerva Neurosciences Short Interest Ratio and Short Volume

+0.01 (+0.32 %)
(As of 03/2/2021 12:00 AM ET)
Today's Range
Now: $3.15
50-Day Range
MA: $3.26
52-Week Range
Now: $3.15
Volume299,210 shs
Average Volume822,077 shs
Market Capitalization$134.42 million
P/E RatioN/A
Dividend YieldN/A

Short Interest

Minerva Neurosciences (NASDAQ:NERV) Short Interest Data

Current Short Volume2,150,000 shares
Previous Short Volume2,020,000 shares
Change Vs. Previous Month:+6.44%
Dollar Volume Sold Short$6.67 million
Short Interest Ratio / Days to Cover2.4
Last Record DateFebruary, 12 2021
Outstanding Shares39,030,000 shares
Float Size36,090,000 shares
Short Percent of Float5.96%
Today's Trading Volume299,210 shares
Average Trading Volume822,077 shares
Today's Volume Vs. Average-63.60%

Short Interest Over Time

Minerva Neurosciences (NASDAQ:NERV) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/12/20212,150,000 shares $6.67 million +6.4%6.0%2.4 $3.10
1/29/20212,020,000 shares $6.77 million +6.3%5.8%2.3 $3.35
1/15/20211,900,000 shares $6.04 million -11.6%5.4%2.2 $3.18
12/31/20202,000,000 shares $5.12 million -0.5%5.7%3.3 $2.56
12/15/20202,000,000 shares $4.74 million -0.5%5.7%3.3 $2.37
11/30/20202,010,000 shares $5.19 million -19.9%5.7%3.2 $2.58
11/15/20202,510,000 shares $9.76 million -14.0%7.2%4.8 $3.89
10/30/20202,920,000 shares $10.40 million -12.6%8.2%5.2 $3.56
10/15/20203,340,000 shares $11.12 million -5.7%9.8%4.7 $3.33
9/30/20203,540,000 shares $12.39 million -7.8%10.3%4.2 $3.50
9/15/20203,840,000 shares $12.21 million -13.1%11.2%3.6 $3.18
8/31/20204,420,000 shares $13.22 million -3.9%12.9%3.4 $2.99
8/14/20204,600,000 shares $14.03 million -14.0%13.6%1.3 $3.05
7/31/20205,350,000 shares $18.78 million -17.8%16.2%1.5 $3.51
7/15/20206,510,000 shares $22.72 million -7.0%20.7%1.9 $3.49
6/30/20207,000,000 shares $24.92 million -0.3%22.2%2.1 $3.56
6/15/20207,020,000 shares $26.33 million +118.7%22.3%2.3 $3.75
5/29/20203,210,000 shares $11.49 million +20.2%10.2%1.2 $3.58
5/15/20202,670,000 shares $9.91 million -5.3%8.5%5.3 $3.71
4/30/20202,820,000 shares $40.07 million -5.4%9.0%7.2 $14.21
4/15/20202,980,000 shares $37.40 million +5.7%9.5%8.5 $12.55
3/31/20202,820,000 shares $23.12 million -3.2%9.0%7.8 $8.20
3/13/20202,912,600 shares $17.04 million +4.8%9.3%6.1 $5.85
2/28/20202,780,000 shares $14.48 million -3.5%8.9%6.8 $5.21
2/14/20202,880,000 shares $20.91 million -8.6%9.2%7.2 $7.26

Minerva Neurosciences (NASDAQ:NERV) Short Interest FAQ

speech bubbles
speech bubbles

What is Minerva Neurosciences' current short interest?

Short interest is the volume of Minerva Neurosciences shares that have been sold short but have not yet been covered or closed out. As of February 12th, traders have sold 2,150,000 shares of NERV short. 5.96% of Minerva Neurosciences' shares are currently sold short. View details.

What is a good short interest ratio for Minerva Neurosciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Minerva Neurosciences currently has a short interest ratio of 2.0.

What is a good short interest percentage for Minerva Neurosciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.96% of Minerva Neurosciences' floating shares are currently sold short.

Is Minerva Neurosciences' short interest increasing or decreasing?

Minerva Neurosciences saw a increase in short interest in the month of February. As of February 12th, there was short interest totaling 2,150,000 shares, an increase of 6.4% from the previous total of 2,020,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Minerva Neurosciences' float size?

Minerva Neurosciences currently has issued a total of 42,674,000 shares. Some of Minerva Neurosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Minerva Neurosciences currently has a public float of 36,090,000 shares.

How does Minerva Neurosciences' short interest compare to its competitors?

5.96% of Minerva Neurosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Minerva Neurosciences: Urovant Sciences Ltd. (1.08%), Bicycle Therapeutics plc (0.00%), Eagle Pharmaceuticals, Inc. (11.56%), Basilea Pharmaceutica AG (0.00%), Summit Therapeutics Inc. (1.33%), Wave Life Sciences Ltd. (14.22%), Amryt Pharma plc (0.00%), Syros Pharmaceuticals, Inc. (8.65%), Spectrum Pharmaceuticals, Inc. (0.00%), and Akebia Therapeutics, Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: ViacomCBS Inc. ($6.50 billion), Aon Plc ($5.58 billion), Charter Communications, Inc. ($5.30 billion), Analog Devices, Inc. ($4.97 billion), Snap Inc. ($3.80 billion), Futu Holdings Limited ($2.84 billion), Airbnb, Inc. ($2.40 billion), Discovery, Inc. ($2.35 billion), Snowflake Inc. ($2.07 billion), and The Kroger Co. ($2.00 billion). View all of the most shorted stocks.

What does it mean to sell short Minerva Neurosciences stock?

Short selling NERV is an investing strategy that aims to generate trading profit from Minerva Neurosciences as its price is falling. Minerva Neurosciences' stock is trading up $0.01 today. To short Minerva Neurosciences stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Minerva Neurosciences will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Minerva Neurosciences?

A short squeeze for Minerva Neurosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NERV, which in turn drives the price of the stock up even further.

How often is Minerva Neurosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NERV, twice per month. The most recent reporting period available is February, 12 2021.

This page was last updated on 3/3/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.